ABSTRACT
Cardiovascular disease is the number one cause of mortality worldwide. Risk prediction can help incentivize lifestyle changes and inform targeted preventative treatment. In this work we explore utilizing a convolutional neural network (CNN) to predict cardiovascular disease risk from abdominal CT scans taken for routine CT colonography in otherwise healthy patients aged 50-65. We find that adding a variational autoencoder (VAE) to the CNN classifier improves its accuracy for five year survival prediction (AUC 0.787 vs. 0.768). In four-fold cross validation we obtain an average AUC of 0.787 for predicting five year survival and an AUC of 0.767 for predicting cardiovascular disease. For five year survival prediction our model is significantly better than the Framingham Risk Score (AUC 0.688) and of nearly equivalent performance to method demonstrated in Pickhardt et al. (AUC 0.789) which utilized a combination of five CT derived biomarkers.
Competing Interest Statement
Ronald M Summers receives royalties from iCAD, Philips, PingAn, and ScanMed and research support from PingAn and NVIDIA. Perry J Pickhardt is an adviser or consultant for Zebra Medical Vision and Bracco Diagnostics, and shareholder in Cellectar, Elucent, and SHINE.
Funding Statement
This research was supported in part by the Intramural Research Program of the National Institutes of Health Clinical Center.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This investigation was approved by the Institutional Review Board at the University of Wisconsin and the Office of Human Subjects Research Protection at the NIH Clinical Center.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Co-senior authors.
Data Availability
The summary numerical output of the automated CT-based tools will be shared upon request, subject to an internal review by PJP and RMS to ensure that participant privacy is protected and subject to completion of a data sharing agreement, as well as approval from both the University of Wisconsin School of Medicine & Public Health (Madison, WI, USA) and the US National Institutes of Health Clinical Center (Bethesda, MD, USA). Pending the aforementioned approvals, data sharing will be made in a secure setting, on a per-case-specific manner. Please submit such requests to PJP.
